Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-κB Signaling Pathway in Human Breast Cancer Cells

Figure 4

Effect of Oroxylin A on EMT formation in MDA-MB-231 cells. Cells were treated with 20 μM Oroxylin A for 24 h. E-cadherin (a), N-cadherin (b), and Vimentin (c) mRNAs were measured with qRT-PCR. (d) The expression of E-cadherin, N-cadherin, and Vimentin proteins in the cells was analyzed by western blotting using specific antibodies. Data are expressed as mean ± SD. < 0.05, < 0.01, < 0.001 versus control.

(a)

(b)

(c)

(d)